Using N-NOSE to Detect Recurrence in Stomach and Esophagus Cancers
Author Information
Author(s): Iitaka Sayuri, Kuroda Akihiro, Narita Tomonori, Hatakeyama Hideyuki, Morishita Masayo, Ungkulpasvich Umbhorn, Hirotsu Takaaki, di Luccio Eric, Yagi Koichi, Seto Yasuyuki
Primary Institution: The University of Tokyo
Hypothesis
Can the N-NOSE chemotaxis index serve as a biomarker for postoperative surveillance and recurrence in patients with upper gastrointestinal cancers?
Conclusion
N-NOSE shows potential as an effective follow-up tool for patients with upper gastrointestinal cancer, especially those with vascular invasion.
Supporting Evidence
- The N-NOSE technique demonstrated high accuracy in distinguishing cancer from non-cancer.
- Patients with vascular invasion showed significantly higher chemotaxis indexes in the recurrence group.
- N-NOSE may capture biological changes that other diagnostics miss.
- Urine samples were collected multiple times to track changes over two years.
- Chemotaxis index changes correlated with recurrence in monitored patients.
Takeaway
This study tested a new urine test called N-NOSE to see if it can help find out if stomach or esophagus cancer comes back after treatment.
Methodology
A two-year prospective cohort study involving urine sample collection from 40 patients with gastric and esophageal cancers, analyzed using the N-NOSE technique.
Potential Biases
Potential biases related to patient selection and the small sample size.
Limitations
The study had a small number of patients and few recurrence cases, which may limit the generalizability of the findings.
Participant Demographics
Median age was 71 years, with 30 males and 10 females.
Statistical Information
P-Value
0.018
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website